Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
Tauchi T, Kizaki M, Okamoto S, Tanaka H, Tanimoto M, Inokuchi K, Murayama T, Saburi Y, Hino M, Tsudo M, Shimomura T, Isobe Y, Oshimi K, Dan K, Ohyashiki K, Ikeda Y; TARGET Investigators. Tauchi T, et al. Leuk Res. 2011 May;35(5):585-90. doi: 10.1016/j.leukres.2010.10.027. Epub 2010 Dec 10. Leuk Res. 2011. PMID: 21145591
Clinical association between thyroid disease and immune thrombocytopenia.
Ito S, Fujiwara SI, Murahashi R, Nakashima H, Matsuoka S, Ikeda T, Kawaguchi SI, Toda Y, Ban T, Nagayama T, Umino K, Minakata D, Morita K, Nakano H, Yamasaki R, Ashizawa M, Yamamoto C, Hatano K, Sato K, Oh I, Ohmine K, Kanda Y. Ito S, et al. Among authors: oh i. Ann Hematol. 2021 Feb;100(2):345-352. doi: 10.1007/s00277-020-04343-5. Epub 2020 Nov 9. Ann Hematol. 2021. PMID: 33165625 Clinical Trial.
Associations between the peripheral blood Wilms tumor gene 1 level and both bone marrow blast cells and the prognosis in patients with myelodysplastic syndrome.
Mashima K, Ikeda T, Toda Y, Ito S, Umino K, Minakata D, Nakano H, Morita K, Yamasaki R, Kawasaki Y, Sugimoto M, Ashizawa M, Yamamoto C, Fujiwara S, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y. Mashima K, et al. Among authors: oh i. Leuk Lymphoma. 2019 Mar;60(3):703-710. doi: 10.1080/10428194.2018.1504940. Epub 2018 Sep 6. Leuk Lymphoma. 2019. PMID: 30188227
Factors that predict delayed platelet recovery after autologous stem cell transplantation for lymphoma or myeloma.
Nagayama T, Ashizawa M, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Yamamoto C, Fujiwara SI, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y. Nagayama T, et al. Among authors: oh i. Ann Hematol. 2020 Dec;99(12):2893-2901. doi: 10.1007/s00277-020-04112-4. Epub 2020 Jun 22. Ann Hematol. 2020. PMID: 32572522
Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation.
Nagayama T, Fujiwara SI, Kikuchi T, Onda K, Murahashi R, Nakashima H, Ikeda T, Matsuoka S, Kawaguchi SI, Toda Y, Ito S, Ban T, Umino K, Minakata D, Nakano H, Yamasaki R, Morita K, Ashizawa M, Yamamoto C, Hatano K, Sato K, Oh I, Ohmine K, Kanda Y. Nagayama T, et al. Among authors: oh i. Leuk Lymphoma. 2022 Jul;63(7):1694-1700. doi: 10.1080/10428194.2022.2034159. Epub 2022 Feb 14. Leuk Lymphoma. 2022. PMID: 35156892
Steep neutrophil recovery following unrelated bone marrow transplantation is a major risk factor for the development of acute graft-vs-host disease-a retrospective study.
Nagayama T, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Mashima K, Umino K, Minakata D, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y. Nagayama T, et al. Among authors: oh i. Transpl Int. 2020 Dec;33(12):1723-1731. doi: 10.1111/tri.13741. Epub 2020 Sep 28. Transpl Int. 2020. PMID: 32939883 Free article.
Impact of the soluble interleukin-2 receptor level in the relapsed or refractory phase on the clinical outcome of patients with diffuse large B-cell lymphoma.
Umino K, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Minakata D, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Kanda Y. Umino K, et al. Among authors: oh i. Leuk Lymphoma. 2019 Aug;60(8):1926-1933. doi: 10.1080/10428194.2018.1564824. Epub 2019 Apr 5. Leuk Lymphoma. 2019. PMID: 30947577
1,495 results